A detailed history of Corient Capital Partners, LLC transactions in Abiomed Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 5,298 shares of ABMD stock, worth $0. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,298
Previous 5,283 0.28%
Holding current value
$0
Previous $1.31 Million 0.31%
% of portfolio
0.1%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $3,637 - $4,521
15 Added 0.28%
5,298 $1.31 Million
Q2 2022

Aug 12, 2022

BUY
$224.73 - $338.64 $321,363 - $484,255
1,430 Added 37.11%
5,283 $1.31 Million
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $876,941 - $1.16 Million
3,163 Added 458.41%
3,853 $1.28 Million
Q4 2021

Feb 11, 2022

BUY
$300.63 - $371.35 $5,110 - $6,312
17 Added 2.53%
690 $248,000
Q3 2021

Nov 16, 2021

BUY
$310.19 - $376.2 $208,757 - $253,182
673 New
673 $219,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.